Pharmafile Logo
Pharmafocus logo
Advanced Search

Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease

November 12, 2021
Medical Communications

New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …

News

Blood pressure drugs could protect against type 2 diabetes

November 12, 2021
Medical Communications

Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …

News
mat-napo-pij34zrzeew-unsplash

Trial investigates whether immunosuppressant holiday boosts vaccine protection

November 12, 2021
Medical Communications

A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …

News

Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment

November 12, 2021
Medical Communications

Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …

News

New experimental drug identified for pancreatic cancer treatment

November 11, 2021
Business Services

Professor Shudong Wang, Head of Drug Discovery and Development at the University of South Australia, is hoping to utilise the …

News

NICE recommends mogamulizumab for treatment of ultra-rare blood cancers

November 11, 2021
Business Services

NICE has recommended POTELIGEO (mogamulizumab), manufactured by Kyowa Kirin, as a treatment option for adults in England in Wales with …

News

Study shows cancer treatments could be repurposed as Alzheimer’s drugs

November 11, 2021
Business Services

A new study published in Science Advances has shared that cancer drugs can be repurposed as therapies to be tested …

News

New study confirms role of digital biomarkers in monitoring patients with multiple sclerosis

November 11, 2021
Business Services

Results from a clinical study, published by Ad Scientiam in ‘Multiple Sclerosis and Related Disorders, secure the place of  MSCopilot ® for the …

News

Pfizer ask FDA to authorise COVID booster in adults

November 10, 2021
Research and Development

Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …

News

COMPASS Pathways announce positive results in clinical trial for treatment-resistant depression

November 10, 2021
Research and Development

COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …

News

Pleco Therapeutics partners with Hyloris to develop novel cancer agent

November 10, 2021
Research and Development

Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …

News

UK government to add Bharat Biotech’s Covaxin to list of approved travel vaccines

November 9, 2021
Manufacturing and Production

The UK government has stated that Covaxin is to be added to its list of approved COVID-19 vaccines for international …

News
dna

Harvard researchers target specific cells with gene therapy

November 9, 2021
Manufacturing and Production

A new technique to turn therapeutic genes on in specifically targeted cells has been developed, a potential game-changer in the …

News

Regeneron’s COVID antibody drug provides long term protection in clinical trial

November 9, 2021
Manufacturing and Production

Regeneron Pharmaceuticals have said that a single dose of its antibody COVID cocktail reduces the risk of contracting the virus …

News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …

Appointment

Diabetes drug dapagliflozin recommended by NICE for chronic kidney disease

November 8, 2021
Sales and Marketing

A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic …

News

HLB’s liver cancer treatment awarded Orphan Drug Status by FDA

November 8, 2021
Sales and Marketing

HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …

News

UK government to roll out Merck antiviral pill, Pfizer COVID pill cuts hospitalisations by 89%

November 8, 2021
Sales and Marketing

The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, …

News

FDA decline Emergency Use Authorisation for ZYESAMI® in patients with critical COVID

November 5, 2021
Medical Communications

The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …

News
credit_-_crevis_shutterstock_340710245_720

Pfizer and Entia’s breast cancer home test in final stages

November 5, 2021
Medical Communications

Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025